Linda M. Szyper is Independent Director of the company. Ms. Szyper has served as the Chief Operating Officer at McCann Health since January 2018. From September 2014 to March 2017, Ms. Szyper was the Chief Commercial Officer and President, US Operations at Circassa Pharmaceuticals plc, or Circassa. Prior to joining Circassa, Ms. Szyper was the Chief Development Officer, PHCG Global Development of Publicis Healthcare Group from January 2008 to September 2014. Ms. Szyper holds a MBA from DePaul University's Kellstadt Graduate School of Business and a Bachelor of Science in biomedical engineering from Northwestern University.
Linda Szyper is 54, she's been the Independent Director of Neos Therapeutics Inc since 2018. There are 5 older and 4 younger executives at Neos Therapeutics Inc. The oldest executive at Neos Therapeutics Inc is Alan Heller, 66, who is the Independent Chairman of the Board.
Over the last 9 years, insiders at Neos Therapeutics Inc have traded over $796,275 worth of Neos Therapeutics Inc stock and bought 558,630 units worth $7,201,055 . The most active insiders traders include Jack W Schuler, James E Deerfield Mgmt L.P...., and Bryant Fong. On average, Neos Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $42,698. The most recent stock trade was executed by Richard I Eisenstadt on 12 December 2018, trading 5,000 units of NEOS stock currently worth $10,800.
Neos Therapeutics Inc executives and other stock owners filed with the SEC include: